DGAT-1 inhibitor 2 is primarily used in research and development to study lipid metabolism and its related disorders. It plays a significant role in inhibiting the DGAT-1 enzyme, which is crucial for triglyceride synthesis. By blocking this enzyme, it helps in understanding and potentially managing conditions like obesity, diabetes, and non-alcoholic fatty liver disease (NAFLD). Researchers utilize this compound to explore therapeutic strategies aimed at reducing excessive fat accumulation in tissues. Additionally, it serves as a valuable tool in preclinical studies to evaluate the efficacy and safety of new treatments targeting metabolic syndromes. Its application extends to the development of drugs that can modulate lipid levels, offering potential benefits in improving overall metabolic health.